A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/196 (2006.01) A61K 9/20 (2006.01) A61K 31/195 (2006.01) A61K 9/16 (2006.01)
Patent
CA 2476744
A method of treating a cyclooxygenase-2 dependent disorder or condition comprising administering 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid in an amount effective to treat such a disorder or condition for about 24 hours, comprising administering orally once a day to a human in need of such treatment one or more immediate release pharmaceutical compositions comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid , and compositions suitable for use in such methods.
L'invention concerne une méthode permettant de traiter un trouble ou un état induit par une cyclooxygénase-2 qui consiste à administrer un acide 5-methyl-2-(2'-chloro-6'-fluoroanilino)phénylacétique en quantité efficace pour traiter ledit trouble ou état pendant environ 24 heures, et à administrer oralement une fois par jour à un sujet humain qui a besoin de ce traitement une ou plusieurs compositions pharmaceutiques à libération immédiate comprenant l'acide 5-methyl-2-(2'-chloro-6'-fluoroanilino)phénylacétique. L'invention concerne également les compositions appropriées à utiliser dans ladite méthode.
Holinej Jurij
Joshi Yatindra
Karnachi Anees Abdulquadar
Khaled Maha Y.
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Solid pharmaceutical compositions comprising lumiracoxib does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solid pharmaceutical compositions comprising lumiracoxib, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid pharmaceutical compositions comprising lumiracoxib will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1492928